These vary by state and can be affected by when you discovered your injury
Marketed under the brand names Mounjaro (for diabetes) and Zepbound (for weight management in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity), tirzepatide represents the first dual incretin receptor agonist available in clinical practice
A small number of real human trials have found a topical glutathione lotion: The honest caveat is that the current evidence is still thin (few studies, small groups, short timelines)
If you are dealing with nausea, bloating, or reflux, reducing these can help significantly
Both readouts show that 72 h 5FU treatment increases mitochondrial CI activity
For a deeper look at the role of appetite control in weekly GLP-1 treatment, see our guide on what to do after missing a weekly GLP-1 injection